LIFECORE BIOMEDICAL, INC. Goodwill, Period Increase (Decrease)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Goodwill, Period Increase (Decrease) of $0 for the 12-month period ending 2024-05-26, per its 10-K filed 2024-08-26.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillPeriodIncreaseDecrease · last filed 2024-08-26
- LIFECORE BIOMEDICAL, INC. goodwill, period increase (decrease) for fiscal 2024 was $0.00.
- LIFECORE BIOMEDICAL, INC. goodwill, period increase (decrease) for fiscal 2023 was $0.00.
- LIFECORE BIOMEDICAL, INC. goodwill, period increase (decrease) for fiscal 2022 was $0.00.
| Period end | Goodwill, Period Increase (Decrease) 12 month |
|---|---|
| 2024-05-26 | $0.00 10-K · filed 2024-08-26 |
| 2023-05-28 | $0.00 10-K · filed 2024-08-26 |
| 2022-05-29 | $0.00 10-K · filed 2024-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |